Hemodynamic effects of ketamine in children with congenital heart disease and/or pulmonary hypertension
Congenital Heart Disease · 2018-09 · 13 (5) · 646-654
DOI: 10.1111/chd.12662 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Congenital Heart Disease, online erschienen am 27.09.2018. Verfasst von Rohit S Loomba und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, The Heart Institute, Advocate Children's Hospital, Oak Lawn, Illinois. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
INTRODUCTION: Ketamine is a drug often used for procedural sedation or as adjunct agent for general sedation in children with congenital heart disease. In the clinical realm, there is often confusion regarding the effects of ketamine on hemodynamics, particularly pulmonary vascular resistance and systemic vascular resistance. We performed a meta-analysis of studies investigating the effects of ketamine on hemodynamics. METHODS: A systematic review was conducted to identify studies characterizing the hemodynamic effects of ketamine in children with congenital heart disease. Studies were assessed for quality and those of satisfactory quality with pre- and postketamine hemodynamics for each patient were included in the final analyses. Those not limited to pediatric patients and those not limited to patients with congenital heart disease were excluded from the final analyses. RESULTS: A total of 7 studies with 139 patients were included in the final analyses. Pulmonary vascular resistance, systemic vascular resistance, mean pulmonary artery pressure, mean systemic pressure, heart rate, pH, and arterial oxygen concentration did not significantly change with administration of ketamine. Carbon dioxide concentration did increase significantly by a mean of 1.38 mm Hg with the administration of ketamine. CONCLUSION: Ketamine has minimal impact on hemodynamics in children with congenital heart disease when used at usual clinical doses. Systemic vascular resistance and pulmonary vascular resistance are not significantly altered. Blood gas values are also only minimally affected by ketamine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, The Heart Institute, Advocate Children's Hospital, Oak Lawn, Illinois.
- Department of Pediatrics, Division of Cardiology, The Hospital for Sick Children, Toronto, Ontario, Canada.
- Department of Pediatrics, Section of Critical Care and Cardiology, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas.
Zitieren
APA
Loomba, R. S., Gray, S. B., & Flores, S. (2018). Hemodynamic effects of ketamine in children with congenital heart disease and/or pulmonary hypertension. Congenital Heart Disease, 13(5), 646-654. https://doi.org/10.1111/chd.12662
Vancouver
Loomba RS, Gray SB, Flores S. Hemodynamic effects of ketamine in children with congenital heart disease and/or pulmonary hypertension. Congenital Heart Disease. 2018;13(5):646-654. doi:10.1111/chd.12662
BibTeX
@article{Loomba2018,
author = {Loomba, Rohit S and Gray, Seth B and Flores, Saul},
title = {Hemodynamic effects of ketamine in children with congenital heart disease and/or pulmonary hypertension},
journal = {Congenital Heart Disease},
year = {2018},
volume = {13},
number = {5},
pages = {646--654},
doi = {10.1111/chd.12662}
}
EUVIMED